eCommons@AKU
Woman and Child Health

Division of Woman and Child Health

10-1-2019

Intestinal permeability and inflammation mediate the association
between nutrient density of complementary foods and
biochemical measures of micronutrient status in young children:
results from the MAL-ED study
Benjamin J J. McCormick
Fogarty International Center, NIH, Bethesda, MD, USA.

Laura E. Murray-Kolb
Pennsylvania State University, University Park, PA, USA.

Gwenyth O. Lee
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Kerry J. Schulze
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

A Catharine Ross
Pennsylvania State University, University Park, PA, USA.

See next
page
additional
authors
Follow
this
andfor
additional
works
at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_wc
Part of the Nutrition Commons, and the Pediatrics Commons

Recommended Citation
McCormick, B. J., Murray-Kolb, L. E., Lee, G. O., Schulze, K. J., Ross, A. C., Bauck, A., Lima, A. M., Maciel, B.
L., Turab, A., Bhutta, Z. A., MAL-ED Network Investigators, ., Qureshi, S., Rasheed, M., Soofi, S., Zaidi, A.
(2019). Intestinal permeability and inflammation mediate the association between nutrient density of
complementary foods and biochemical measures of micronutrient status in young children: results from
the MAL-ED study. The American journal of clinical nutrition, 110(4), 1015-1025.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_wc/119

Authors
Benjamin J J. McCormick, Laura E. Murray-Kolb, Gwenyth O. Lee, Kerry J. Schulze, A Catharine Ross,
Aubrey Bauck, Aldo A M. Lima, Bruna L L. Maciel, Ali Turab, Zulfiqar Ahmed Bhutta, MAL-ED Network
Investigators, Shahida Qureshi, Muneera Rasheed, Sajid Bashir Soofi, and Anita K. M. Zaidi

This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_wc/
119

Intestinal permeability and inflammation mediate the association
between nutrient density of complementary foods and biochemical
measures of micronutrient status in young children: results from the
MAL-ED study
Benjamin JJ McCormick,1 Laura E Murray-Kolb,2 Gwenyth O Lee,3 Kerry J Schulze,3 A Catharine Ross,2 Aubrey Bauck,3
Aldo AM Lima,4 Bruna LL Maciel,5 Margaret N Kosek,3 Jessica C Seidman,1 Ramya Ambikapathi,1 Anuradha Bose,6
Sushil John,6 Gagandeep Kang,6 Ali Turab,7 Estomih Mduma,8 Pascal Bessong,9 Sanjaya K Shrestra,10 Tahmeed Ahmed,11
Mustafa Mahfuz,11 Maribel Paredes Olortegui,12 Zulfiqar Bhutta,7 and Laura E Caulfield3 for the MAL-ED Network
Investigators
1 Fogarty

International Center, NIH, Bethesda, MD, USA; 2 Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA,
USA; 3 Department of International Health, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; 4 Universidade Federal do Ceará,
INCT—Instituto de Biomedicina do Semiárido Brasileiro, Fortaleza, Brazil; 5 Department of Nutrition, Federal University of Rio Grande do Norte, Natal, Rio
Negro, Brazil; 6 Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India; 7 Centre of Excellence in Women and Child Health, Aga Khan
University, Karachi, Pakistan; 8 Haydom Lutheran Hospital, Haydom, Tanzania; 9 University of Venda, Thohoyandou, South Africa; 10 Walter Reed, Armed
Forces Research Institute of Medical Sciences (AFRIMS) Research Unit, Nepal (WARUN), Kathmandu, Nepal; 11 Division of Nutrition and Clinical Services,
icddr,b, Dhaka, Bangladesh; and 12 AB Prisma, Iquitos, Peru

ABSTRACT
Background: Environmental enteric dysfunction (EED) is thought
to increase the risk of micronutrient deficiencies, but few studies
adjust for dietary intakes and systemic inflammation.
Objective: We tested whether EED is associated with micronutrient
deficiency risk independent of diet and systemic inflammation, and
whether it mediates the relation between intake and micronutrient
status.
Methods: Using data from 1283 children in the MAL-ED (Etiology,
Risk Factors, and Interactions of Enteric Infections and Malnutrition
and the Consequences for Child Health) birth cohort we evaluated
the risk of anemia, low retinol, zinc, and ferritin, and high transferrin
receptor (TfR) at 15 mo. We characterized gut inflammation and
permeability by myeloperoxidase (MPO), neopterin (NEO), and α-1antitrypsin (AAT) concentrations from asymptomatic fecal samples
averaged from 9 to 15 mo, and averaged the lactulose:mannitol ratio
z-score (LMZ) at 9 and 15 mo. Nutrient intakes from complementary
foods were quantified monthly from 9 to 15 mo and densities were
averaged for analyses. α-1-Acid glycoprotein at 15 mo characterized
systemic inflammation. Relations between variables were modeled
using a Bayesian network.
Results: A greater risk of anemia was associated with LMZ [1.15
(95% CI: 1.01, 1.31)] and MPO [1.16 (1.01, 1.34)]. A greater risk of
low ferritin was associated with AAT [1.19 (1.03, 1.37)] and NEO
[1.22 (1.04, 1.44)]. A greater risk of low retinol was associated with
LMZ [1.24 (1.08, 1.45)]. However, MPO was associated with a lower
risk of high transferrin receptor [0.86 (0.74, 0.98)], NEO with a lower
risk of low retinol [0.75 (0.62, 0.89)], and AAT with a lower risk of

low plasma zinc [0.83 (0.70, 0.99)]. Greater nutrient intake densities
(vitamins A and B6, calcium, protein, and zinc) were negatively
associated with EED. Inverse associations between nutrient densities
and micronutrient deficiency largely disappeared after adjustment for
EED, suggesting that EED mediates these associations.
Conclusions: EED is independently associated with an increased
risk of low ferritin, low retinol, and anemia. Greater nutrient density
from complementary foods may reduce EED, and the control of
micronutrient deficiencies may require control of EED.
Am J
Clin Nutr 2019;110:1015–1025.
Keywords: environmental enteropathy, intestinal barrier function,
inflammation, micronutrient status, diet

Introduction
Micronutrient deficiencies affect millions of young children in
low- and middle-income countries and compromise their growth
and well-being (1, 2). Major causes of micronutrient deficiencies
are inadequate dietary intake and impairments in absorption and
modulation of tissue availability of the nutrient to meet metabolic
requirements (3).
Repeated enteropathogen infections or subclinical infections
can damage the gut and produce a condition called environmental
enteric dysfunction (EED) (4, 5), characterized by abnormal
morphology (altered crypt depth and villus height, diagnosed
via biopsy) (5, 6). For several decades, a noninvasive test of
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EED, the lactulose:mannitol (LM) test of intestinal absorption,
permeability, and damage, has been used to study EED among
children. Recently, researchers have also utilized fecal and blood
biomarkers of the immune system to characterize additional
aspects of EED (7, 8). It is proposed that EED, due to changes
in gut architecture and increases in both local gut and subsequent
systemic inflammation, may be associated with micronutrient
deficiencies, through impaired nutrient absorption, increased
requirements, nutrient sequestration, or a combination thereof
(9).
Studies that directly evaluate the impact of altered gut function
on micronutrient absofrption in children are rare (9). Manary et al.
(10) found that increased gut permeability in Malawian children
aged 3–5 y (assessed using the LM test) was positively associated
with endogenous fecal zinc but negatively with net zinc retention,
suggesting altered zinc homeostasis (10). Studies evaluating
associations between intestinal permeability and indicators of
micronutrient status in children are also limited. In crosssectional studies, children with a higher LM ratio had lower
serum iron and/or were more likely to have anemia (11, 12), and
an increased concentration of calprotectin, a fecal biomarker of
neutrophil activation, has been associated with lower plasma zinc
concentrations (13, 14).
Proteins, vitamin A, and zinc are critical nutrients for
maintaining epithelial integrity and promoting immune responses
essential for gut health (15), and a low intake of these and
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other nutrients may exacerbate EED. In previous studies of
diet and systemic inflammation, diets providing more vitamin
A and zinc (along with vitamins C, D, and E and other
antioxidants) have been considered anti-inflammatory (16). In
contrast, iron fortification has been reported to increase the LM
ratio (i.e., exacerbating EED) (17) and intestinal inflammation
(18), and excess dietary iron is hypothesized to be proinflammatory because it may alter gut microbial populations and, in
turn, lead to increased morbidity and systemic inflammation
(19–21).
The “Etiology, Risk Factors, and Interactions of Enteric
Infections and Malnutrition and the Consequences for Child
Health” (MAL-ED) 8-site birth cohort study (22) was designed
to study the impact of diet, morbidity, and gut function on child
growth, cognitive development, and vaccine response (23–25).
Here, we use longitudinal measures of diet and gut function
to evaluate whether intestinal permeability and inflammation
[which are influenced by exposure to enteropathogens (8)] affect
the risk of micronutrient deficiency in children aged 15 mo,
adjusting for dietary intake and other factors.

Methods
The MAL-ED study was conducted in 8 populations: Dhaka,
Bangladesh (BGD); Fortaleza, Brazil (BRF); Vellore, India
(INV); Bhaktapur, Nepal (NEB); Loreto, Peru (PEL); Naushero
Feroze, Pakistan (PKN); Venda, South Africa (SAV); and
Haydom, Tanzania (TZH) (22). Briefly, infants were enrolled
within 17 days of birth, if they were born singleton with
a birth weight >1500 g, without serious illnesses, to a
mother aged ≥16 y, and to a family planning to stay in the
community for ≥6 mo. Children were followed until aged 24
mo. Each site enrolled children with the goal of obtaining
information until 24 mo on ∼200 children, accounting for loss
to follow-up. Each site obtained ethical approval from their
respective institutions, and written consent was obtained from the
parents.
Here, we focus on the period from 9 to 15 mo of age, because
it is a period of risk of the development of micronutrient deficiencies due to inadequate nutrient intake from complementary foods
and because of the temporal alignment of the key exposures of
dietary intake, gut permeability, and inflammation leading to the
end point of micronutrient status at 15 mo. The methods of data
collection for infant feeding, dietary intakes and micronutrient
status, disease surveillance, and stool microbiology are described
elsewhere (26–28) and brief details are provided below (the
timeline of data collection is described in Supplemental
Figure 1).
Starting at enrollment, and through twice-weekly surveillance
visits, caregivers were asked about breastfeeding and nonbreast
milk food consumption (26). Mothers also reported whether the
child had experienced illness in the preceding days (27). Monthly,
the mother/caregiver was interviewed to further characterize
breastfeeding and the introduction of complementary foods.
When children reached 9 mo of age, their energy, macro-, and
micronutrient intake from nonbreast milk foods were estimated
monthly using a quantitative 24-h recall (26). Breast milk intake
was not quantified.

Gut dysfunction and micronutrient status

Caregivers were also queried about provision of nutritional
supplements to the child through the healthcare system. For
analyses, reported supplements were categorized broadly as
containing: 1) iron; 2) multivitamins with or without minerals
(MVM); 3) zinc; 4) vitamin B complex or folate; 5) vitamin
D; 6) vitamin A; 7) herbals; 8) amino acids; and 9) multiple
micronutrients in powders (MNP) (BGD and PEL only).
To characterize aspects of gut function that are indicative
of EED, normal, i.e., not diarrheal, stools were collected for
analysis monthly during the first year and quarterly in the second
year. From these stool samples, 3 biomarkers were analyzed:
myeloperoxidase (MPO), neopterin (NEO), and α-1-antitrypsin
(AAT) (28). Briefly, MPO is a marker of neutrophil activation,
NEO indicates T-helper cell activity, and AAT is a marker for
protein loss and intestinal permeability.
To evaluate intestinal barrier function, children were administered the LM test aged 9 and 15 mo; test administration
and laboratory procedures are reported elsewhere (28). From
the test, urinary recovery of lactulose (%) and mannitol (%)
were determined as well as their ratio. We have previously
demonstrated the importance of normalizing the values to a
reference to remove differences due to age and sex (29); therefore,
the results are expressed as z-scores referred to as lactulose zscore (%Lac-Z), mannitol z-score (%Man-Z), and their ratio as
LMZ.
Venous blood samples were collected at 15 mo to characterize
the status of vitamin A (plasma retinol), zinc (plasma zinc), and
iron [plasma ferritin and transferrin receptor (TfR)]. A fingerprick blood sample was also obtained to determine hemoglobin
concentration using the HemoCue method (30). Retinol was
determined using HPLC (31) and plasma zinc was determined
using atomic absorption spectrophotometry (32). Plasma ferritin
and TfR were determined using immunoturbidimetry (BGD and
PKN; Hitachi 902 analyzer), chemiluminescence (INV; Hitachi
912 analyzer), or by enzyme immunoassay calibrated against
WHO-certified values (all other sites; Ramco Laboratories
Inc.). Plasma α-1-acid glycoprotein (AGP) as a measure of
systemic inflammation was determined by autoanalyzers (as
above) or using radial immunodiffusion (Kent Laboratories); it
was considered elevated at concentrations >1 g/L. Laboratories
participated in global laboratory standardization programs using
Standard Reference Materials produced by the National Institute
of Standards and Technology, and used quality control materials
with certified concentrations of analytes of interest in a human
serum or plasma matrix to ensure assay quality and agreement
across sites.
To report the prevalence of micronutrient deficiencies, we
adjusted the distributions of each biochemical indicator for
inflammation per Biomarkers Reflecting Inflammation and
Nutritional Determinants of Anemia guidelines (33). Vitamin
A deficiency was defined as a retinol concentration <0.70
μmol/L, zinc deficiency as a zinc concentration <9.9 μmol/L,
iron deficiency as a plasma ferritin concentration <12 μg/L,
and TfR was defined as elevated if the concentration was >8.3
mg/L. Hemoglobin was adjusted for altitude where appropriate
(NEB and TZH) (34), and anemia was identified by hemoglobin
<11.0 g/dL. The plasma zinc concentrations for the SAV site
indicated contamination in initial sample processing and because
we planned to examine associations amongst indicators of
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micronutrient deficiency simultaneously, we therefore excluded
the SAV data from these analyses.
Sample size and statistical analyses
Of the 1831 children enrolled across the 7 sites, 1574 (86%)
remained in the study at 15 mo, and of those, 1491 (95%) had
a blood draw at 15 (or 16) mo (Figure 1). The completeness of
the biochemical determinations for some children was limited by
sample volume and condition; the protocol prioritized the assays
based on potential associations with the primary outcomes of
child growth and development, and plasma retinol had the lowest
priority. Of the 175 children with incomplete micronutrient status
data, 124 (71%) did not have a plasma retinol determination.
From 9 to 15 mo, a maximum of 7 assessments of intake
from complementary foods, 5 assessments of gut function, and
2 assessments of barrier function were available. Thirty-one
children had missing data for other key variables, resulting in a
final analytic sample size of 1283 children (assuming completecases analysis, 82% of children in the study at 15 mo, ranging
from 55% in TZH to 91% in NEB).
The concentration of the 3 fecal biomarkers were logtransformed and the mean was then calculated over observations
from 9 to 15 mo. The mean of the 2 urinary %Lac-Z, %ManZ, and LMZ measurements at 9 and 15 mo were also calculated
with the interpretation of a higher LMZ as indicative of greater
gut dysfunction, a higher %Lac-Z of greater permeability, and a
higher %Man-Z as greater surface area for absorption.
Mean intake from nonbreast milk foods was calculated from 9
to 15 mo. To describe the dietary pattern, macronutrient intake
is presented by the % contribution to energy intake. During
analyses, we evaluated macro- and micronutrient densities
(intake per 1000 kcal and subsequently transformed using a
square-root function), including the intake of protein, vitamins
(A, B6, B12, C, and folate), and minerals (calcium, zinc, and
iron). Breastfeeding is described by the proportion of days a child
was breastfed between 9 and 15 mo.
Univariate associations between nutrient density (squareroot transformed and standardized to mean 0, SD 1) and the
micronutrient status variables (binary) or the markers of EED and
inflammation (on a log scale, then standardized) were calculated
using generalized mixed models including site as a random
intercept.
Bayesian network analysis allows the evaluation of statistical associations amongst variables including one or more
outcome measures (35, 36). Using the conceptual framework
(Figure 2), a Bayesian network (35, 37) was developed to
document hypothesized relations between diet and micronutrient
status, diet and gut inflammation, permeability and systemic
inflammation, and their associations with micronutrient status.
Because we were interested in evaluating the association of
AGP with other variables, we utilized noninflammation-adjusted
biochemical values and explicitly included (log-transformed)
AGP in the model. The Bayesian network was constructed as
conditionally independent generalized linear regressions using
JAGS 4.2.0 (http://mcmc-jags.sourceforge.net)(38). Coefficients
are interpreted as the mean effect of a unit change in an ancestor
(a predictor variable) from which an arc (arrow) originates on
a descendent (dependent variable) where the arc ends, as one
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BGD

INV

NEB

PKN

BRF

PEL

TZH

Total

Enrolled

265

251

240

227

233

303

262

1831

Blood draw at
15–16
15-16m
mo

196

228

226

243

153

224

221

1491

missing anemia

1

0

0

0

1

1

0

3

missing retinol

4

1

3

9

12

17

78

124

missing TfR

0

1

0

0

0

3

2

6

missing AGP

0

0

0

0

0

0

0

0

missing zinc

0

0

0

1

0

0

0

1

missing ferritin

3

5

13

13

0

7

0

41

missing LMZ

1

0

0

10

2

0

12

25

missing fecal
biomarkers

0

1

0

3

4

0

0

8

187

220

210

207

134

196

129

1283

Analytic total

FIGURE 1 Cohort profile by site. AGP, α-1-acid glycoprotein; BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; INV, Vellore, India; LMZ,
lactulose:mannitol ratio z-score; NEB, Bhaktapur, Nepal; PEL, Loreto, Peru; PKN, Naushero Feroze, Pakistan; TfR, transferrin receptor; TZH, Haydom,
Tanzania.

would with a linear regression. We hypothesized a mediating
role of the gut function biomarkers such that relations between
nutrient intake and micronutrient status would be determined (at
least partially) by degrees of gut inflammation and permeability.
Each node (i.e., the micronutrient outcomes and gut function
variables) included additional dummy variables to adjust for site.
To fit the model, the diet, gut biomarker, LMZ, and AGP variables
were standardized. Mean effects (for continuous biomarkers)
and OR (for binary micronutrient status biomarkers) per 1 SD
difference and 95% credibility interval are reported for selected
results.

were reported for TZH or BRF. We conducted sensitivity analyses
to evaluate the impact of including variables for MVM and MNP,
and iron and zinc supplements in the Bayesian network. Provision
of iron supplements was associated with a lower risk of anemia
at 15 mo in PEL, but it did not affect the observed relations
amongst diet, gut function, and micronutrient status. Therefore,
we did not adjust for them in the Bayesian network presented
here.

Results
Sensitivity analyses
From 9 to 15 mo as well as in the days proximate to the blood
draw at 15 mo, fever as reported by the mother was recorded.
Three variables (proportion of days with fever 9–15 mo; fever <7
d prior – or fever <7 d following – the blood draw) were included
in generalized linear mixed models as additional markers of
systemic inflammation in order to evaluate their influence on
the risk of the micronutrient status outcomes and on the other
coefficients in the model.
The provision of nutritional supplements to children varied
widely across the sites; for example, between 9 and 15 mo, 87%
of children in PEL received iron supplements, but no supplements

Characteristics of the subset of the MAL-ED population
included in these analyses are shown for biomarkers of gut
function and micronutrient status in Table 1. Each of the
fecal biomarkers and LMZ were elevated when compared with
available reference data (29, 39). Children were reported to spend
0.5–10.8% days with fever, at 15 mo, 40–69% of children had
an elevated AGP concentration, and 5–35% of children had
fever near the time of the blood draw (Supplemental Table
1). The prevalence of anemia ranged from 40% in BRF to
88% in PKN. Prevalence of other micronutrient deficiencies
differed similarly across sites: low plasma retinol ranged from
6% in BRF to 61% in TZH; and low plasma zinc ranged
from 2% in BRF to 73% in INV. The prevalence of high TfR
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Nutrient densities
from complementary
foods

Biomarkers of gut
inflammation
(MPO, NEO),
gut permeability
(AAT, LMZ)

Systemic
inflammation

low
zinc

zinc
iron
calcium
protein
folate

Micronutrient status

LMZ

AAT

high
TfR
AGP

low
ferritin

NEO

low
retinol

MPO

anemia

vitamin
C
vitamin
B12
vitamin
B6
vitamin
A

FIGURE 2 Schematic of the model used to examine hypothetical relations between variables. Nutrient intake densities from complementary foods
are related to fecal biomarkers of inflammation (MPO, myeloperoxidase; NEO, neopterin) to markers of permeability (AAT, α-1-antitrypsin; LMZ,
lactulose:mannitol ratio z-score) and to plasma biomarkers of nutrient status, which are also affected by systemic inflammation (AGP, α-1-acid glycoprotein).
The plasma biomarkers (including AGP) were measured at 15 mo, whereas all other variables are the averages from 9 to 15 mo (LMZ was measured at 9 and
15 mo only). TfR, transferrin receptor.

ranged from 11% in TZH to 72% in BRF, but the prevalence
of low plasma ferritin was more similar across sites, affecting
51% of children in most sites, although as much as 82% in
PKN. Ferritin concentration was negatively correlated with TfR
(mean Spearman’s ρ: −0.32 [95% CI: −0.37, −0.26]) and
positively correlated with hemoglobin concentration [0.40 (0.35,
0.44)], whereas TfR was negatively correlated with hemoglobin
concentration [−0.24 (−0.28, −0.19)]. The 3 fecal biomarkers
were correlated with each other (ρ ∼0.3; Supplemental Figure
2) but less so with LMZ and AGP (ρ ∼0.1–0.2).
The median energy intake from complementary foods (9–
15 mo inclusive) differed among the 7 sites, ranging from
240 kcal/d in BGD to 880 kcal/d in BRF (Table 2). These
differences were driven by the site-to-site variations in infant
feeding practices, the introduction of nonbreast milk foods prior
to 6 mo, and differences in continued breastfeeding through to
15 mo. Between 53% and 70% of the energy consumed from
complementary foods was from carbohydrates, ∼11–17% from
protein, and the remainder from fat. The nutrient densities were
correlated with one another to varying degrees (ρ ∼0.1–0.7,
Supplemental Figure 2).
Adjusting for inflammation and site, nutrient densities
from complementary foods as well as biomarkers of EED were
associated with the risk of micronutrient deficiency (Table 3).
Greater vitamin A nutrient density was associated with a lower
risk of low plasma retinol, and greater iron nutrient density was
associated with a lower risk of anemia, low ferritin, and low

retinol, but not with a risk of high TfR. No statistically significant
associations between diet and zinc status were detected. The risk
of anemia and low retinol were associated with greater LMZ,
and the risk of low ferritin was associated with AAT. Inverse
associations were also observed: NEO with a lower risk of low
retinol, MPO with a lower risk of high TfR, and AAT with a lower
risk of low plasma zinc.
In univariate analyses (adjusted for site), the nutrient densities
from complementary foods were negatively associated with
biomarkers of gut permeability and inflammation, and with
systemic inflammation (Table 4). Only the zinc density of
the diet was negatively associated with LMZ; this association
was due to a negative association between zinc density and
permeability [%Lac-Z: −0.15 (−0.25, −0.05)]. Based on the
univariate results, 2 variables, folate and vitamin C, were dropped
from the multivariable model: neither folate nor vitamin C
had associations with the micronutrient status or gut function
variables, and furthermore, folate was colinear with vitamins B6
and B12 that were retained in the model.
The results of the Bayesian network are sho wn in Figure
3 (with all associations shown in Supplemental Figure 3 and
numerical results in Supplemental Table 2) with the colors
indicating the direction of the association (red, positive; blue,
negative) for the relations of diet with gut function biomarkers
and AGP, or the log odds for the associations with micronutrient
deficiency. Low ferritin, low retinol, and high TfR were each
strongly associated with a higher risk of anemia: low ferritin [2.79
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TABLE 1 Indicators of gut function, micronutrient status, and inflammation by MAL-ED study site1

Children in analysis, n
Urinary biomarkers
%Lac-Z2
%Man-Z2
LMZ2
Fecal biomarkers
MPO ln(ng/mL)3
NEO ln(nmol/L)3
AAT ln(μg/g)3
Biomarkers of micronutrient
status
Hemoglobin, g/dL4
Retinol, μmol/L5
TfR, mg/L5
Ferritin, μg/L5
Zinc, μmol/L5
Inflammation
AGP g/L
Inflamed, %6
Fever, %

BGD

INV

NEB

PKN

BRF

PEL

TZH

187

220

209

207

133

196

129

1.5 ± 0.74
0.87 ± 0.68
0.29 ± 0.67

2.3 ± 0.77
1.2 ± 0.76
0.84 ± 0.67

0.81 ± 0.72
0.66 ± 0.87
0.062 ± 0.8

1.1 ± 1.1
0.35 ± 1
0.68 ± 0.84

0.047 ± 0.74
0.016 ± 0.78
0.039 ± 0.74

1.5 ± 0.81
0.23 ± 0.69
1 ± 0.54

0.092 ± 1.3
−0.19 ± 0.99
0.39 ± 1.3

8.5 ± 0.8
6.8 ± 0.82
−1 ± 0.61

8.8 ± 0.65
7.5 ± 0.67
−1.1 ± 0.65

8.5 ± 0.74
7.6 ± 0.44
−0.93 ± 0.57

8.1 ± 0.88
6.3 ± 0.58
−2 ± 0.78

8 ± 1.2
7.4 ± 0.71
−1.4 ± 0.75

8.8 ± 0.88
7.9 ± 0.53
−0.84 ± 0.59

8.2 ± 0.76
6.5 ± 0.95
−1.4 ± 0.86

11 ± 1.5
27.2 ± (9)
7.2 ± 3.7
12.7 ± 9.4
11.5 ± 1.7

11 ± 1.3
31.4 ± 9.5
4.9 ± 3.6
10.5 ± 13.3
9.2 ± 1.3

11 ± 1.2
30.4 ± 7.5
9.5 ± 4.3
10.2 ± 36
12.3 ± 5.2

9.3 ± 1.4
21.4 ± 8.3
7 ± 5.1
9.2 ± 14.2
8.5 ± 2.6

11 ± 2.2
35.1 ± 9.7
9.9 ± 2.5
15.1 ± 9.2
14.9 ± 4

11 ± 1.2
24.9 ± 6.9
7.4 ± 2.6
17.1 ± 19.5
17 ± 6.6

11 ± 1.2
18.9 ± 6.4
5.1 ± 3
10.8 ± 9.3
11.6 ± 2.5

0.96 ± 0.32
42.0
6.6 (4.4, 9.4)

0.99 ± 0.36
40.1
5.6 (3.8, 8.5)

1.20 ± 0.41
66.2
4.7 (2.3, 7.5)

0.98 ± 0.41
43.3
10.8 (7, 16)

1.10 ± 0.37
48.5
0.5 (0, 0.9)

1.20 ± 0.45
66.5
4.2 (2.3, 6.1)

1.20 ± 0.40
68.8
1.9 (0.5, 3.3)

1 Values are mean ± SD except for the % follow-up of fever (9–15 mo), which is the median (IQR). AAT, α-1-antitrypsin; AGP, α-1 acid glycoprotein;
BGD, Dhaka, Bangladesh; BRF, Fortaleza, Brazil; INV, Vellore, India; %Lac-Z, lactulose recovery z-score; LMZ, lactulose:mannitol ratio z-score; %Man-Z,
mannitol recovery z-score; MAL-ED, Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health;
MPO, myeloperoxidase; NEB, Bhaktapur, Nepal; NEO, neopterin; PEL, Loreto, Peru; PKN, Naushero Feroze, Pakistan; TfR, transferrin receptor; TZH,
Haydom, Tanzania.
2 Mean z-scores controlling for age and sex from 9 and 15 mo old, centered on the BRF data.
3 Mean natural log-transformed concentrations from 9 to 15 mo.
4 Hemoglobin adjusted for altitude where applicable (NEB and TZH).
5 Values at 15 mo adjusted for inflammation [AGP, see (33)].
6 Percentage of children with AGP ≥1.0 g/L

(2.09, 3.68)]; low retinol [1.58 (1.16, 2.15)]; high TfR [2.26 (1.68,
3.09)]. However, low zinc concentration was not [0.93 (0.64,
1.29)]. All of the indicators except zinc were also affected by
systemic inflammation; higher AGP was associated with a greater
risk of low plasma retinol [1.58 (1.38, 1.83)], elevated TfR [1.18

(1.03, 1.33)], and anemia [1.29 (1.12, 1.49)], and with a lower
risk of low ferritin [0.62 (0.54, 0.70)].
Biomarkers of gut function were associated with the risk of
micronutrient deficiency. A greater risk of anemia was associated
with greater intestinal permeability [LMZ: 1.15 (1.01, 1.31)] and

TABLE 2 Usual intakes of energy and macro- and micronutrients from complementary foods at 9–15 mo by MAL-ED study site1
BGD
Energy, kcal
240 ±120
Carbohydrate, %E
64 ± 6.8
Protein, %E
12 ± 1.9
Fat, %E
20 ± 5.4
Nutrient densities (per 1000 kcal)
Iron, mg
4.1 (3.2, 4.8)
Zinc, mg
3.5 (3.1, 3.9)
Calcium, mg
320 (150, 450)
Vitamin A, μg
190 (94, 250)
Vitamin B6, μg
0.8 (0.7, 1.0)
Folate, μg
110 (83, 130)
Vitamin B12, μg
1.5 (0.8, 2)
Vitamin C, mg
36 (15, 45)
Breastfed, proportion of days
1 (1, 1)

INV
580 ± 250
61 ± 6.5
11 ± 1.6
24 ± 6.3
3.4 (3, 3.7)
4 (3.6, 4.4)
440 (220, 640)
230 (130, 330)
0.4 (0.3, 0.5)
120 (100, 130)
0.7 (0.4, 1.1)
13 (10, 14)
1 (0.7, 1)

NEB
300
58
11
27

±
±
±
±

130
7.7
2.4
7.1

3.6 (2.6, 4.1)
3.5 (3, 4)
330 (180, 450)
210 (130, 280)
0.6 (0.5, 0.7)
120 (85, 140)
1.3 (0.7, 1.8)
19 (9.2, 23)
1 (1, 1)

PKN
460
53
11
33

±
±
±
±

230
8.7
2
8.8

3.3 ±(2.3, 4.1)
3.3 (2.9, 3.6)
550 (360, 710)
250 (160, 320)
0.7 (0.5, 0.9)
95 (73, 110)
1.5 (0.8, 2)
19 (10, 23)
1 (0.9, 1)

BRF
880
53
17
28

±
±
±
±

270
3.9
2.3
3.2

14 (11, 17)
9.2 (7.9, 11)
1100 (1000, 1200)
1100 (940, 1200)
1.2 (0.8, 1.4)
180 (150, 190)
5.1 (4.6, 5.3)
120 (88, 130)
1 (0.5, 1)

PEL
510
70
11
19

±
±
±
±

180
5.7
2.2
4.5

5.9 (3.2, 6.2)
3.1 (2.6, 3.4)
360 (170, 470)
430 (200, 500)
0.5 (0.4, 0.6)
93 (67, 100)
1.7 (0.9, 2.1)
110 (27, 120)
1 (1, 1)

TZH
850
65
12
19

±
±
±
±

220
6.8
1.8
5.9

7.7 (6.8, 8.5)
5.5 (5.2, 5.7)
490 (270, 690)
170 (110, 210)
0.1 (0.1, 0.2)
69 (58, 78)
1.7 (0.9, 2.5)
5.4 (2.4, 6.9)
1 (1, 1)

are based on the means of ≤7 monthly measures of intake per child. Energy and macronutrient intakes expressed as mean ± SD, and
macronutrients are expressed as % of energy (%E). Micronutrient densities per 1000 kcal are shown as median (25th, 75th percentile). BGD, Dhaka,
Bangladesh; BRF, Fortaleza, Brazil; INV, Vellore, India; MAL-ED, Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the
Consequences for Child Health; NEB, Bhaktapur, Nepal; PEL, Loreto, Peru; PKN, Naushero Feroze, Pakistan; TZH, Haydom, Tanzania.
1 Intakes
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TABLE 3 ORs (95% CI) for micronutrient deficiency associated with a 1-SD change in nutrient density in complementary foods or in biomarkers of EED1
Variable

Anemia

Usual nutrient density, SD [sqrt(intake/1000 kcal)]
Iron, mg
0.78 (0.64, 0.94)∗
Zinc, mg
0.89 (0.71, 1.1)
Calcium, mg
1.04 (0.9, 1.21)
Vitamin A, μg
1.22 (1.02, 1.46)∗
Vitamin B6, μg
0.85 (0.71, 1.02)
Folate, μg
1.02 (0.88, 1.17)
Vitamin B12, μg
1.09 (0.93, 1.29)
Vitamin C, mg
1.05 (0.89, 1.23)
Protein, g
1.02 (0.88, 1.19)
Biomarker of EED
MPO, SD[log(ng/mL)]
1.10 (0.97, 1.24)
NEO, SD[log(nmol/L)]
1.00 (0.86, 1.17)
AAT, SD[log(μg/g)]
1.00 (0.87, 1.15)
LMZ, SD
1.19 (1.03, 1.36)∗

Low plasma ferritin

High transferrin receptor

Low plasma retinol

Low plasma zinc

0.66 (0.54, 0.79)∗
0.80 (0.64, 1.01)
1.02 (0.88, 1.18)
0.94 (0.78, 1.14)
0.86 (0.71, 1.03)
0.89 (0.76, 1.02)
1.02 (0.86, 1.2)
0.84 (0.7, 1.01)
1.09 (0.93, 1.28)

0.88 (0.73, 1.07)
1.05 (0.84, 1.32)
1.19 (1.02, 1.39)∗
1.14 (0.95, 1.38)
1.00 (0.82, 1.21)
0.9 (0.77, 1.04)
1.12 (0.94, 1.32)
1.04 (0.89, 1.23)
1.04 (0.89, 1.22)

0.71 (0.57, 0.88)∗
0.59 (0.45, 0.78)∗
0.72 (0.61, 0.86)∗
0.81 (0.67, 1.00)∗
0.99 (0.80, 1.21)
0.89 (0.76, 1.05)
0.83 (0.69, 0.99)∗
1.06 (0.89, 1.26)
0.85 (0.72, 1.01)

0.76 (0.55, 1.06)
1.26 (0.88, 1.80)
1.16 (0.97, 1.39)
1.14 (0.88, 1.47)
1.05 (0.82, 1.34)
0.87 (0.71, 1.07)
1.14 (0.93, 1.41)
1.01 (0.75, 1.35)
1.18 (0.96, 1.44)

0.97 (0.85, 1.09)
1.19 (1.02, 1.39)∗
1.13 (0.99, 1.29)∗
0.93 (0.82, 1.07)

0.85 (0.75, 0.96)∗
1.13 (0.96, 1.33)
0.94 (0.82, 1.08)
0.89 (0.77, 1.02)

1.12 (0.97, 1.29)
0.77 (0.66, 0.92)∗
1.04 (0.90, 1.20)
1.34 (1.15, 1.57)∗

0.94 (0.80, 1.11)
1.02 (0.85, 1.23)
0.81 (0.69, 0.96)∗
0.98 (0.84, 1.15)

1 Presented are the log odds, adjusted for site and α-1-acid glycoprotein. Nutrient densities were transformed using square root; MPO, NEO, and AAT
were transformed using a natural logarithm. ∗ indicates associations that do not include 1.0 in the 95% CI. AAT, α-1-antitrypsin; EED, environmental enteric
dysfunction; LMZ, lactulose:mannitol ratio z-score; MAL-ED, Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the
Consequences for Child Health; MPO, myeloperoxidase; NEO, neopterin.

inflammation [higher MPO: 1.16 (1.01, 1.34)]. A greater risk of
low ferritin was associated with both AAT [1.19 (1.03, 1.37)] and
NEO [1.22 (1.04, 1.44)]. Only MPO was associated with a risk of
high TfR, and it was protective [0.86 (0.74, 0.98)]. A greater risk
of low retinol was also associated with permeability [LMZ: 1.24
(1.08, 1.45)], but inversely with NEO [0.75 (0.62, 0.89)]. Finally,
AAT was associated with a lower risk of low plasma zinc [0.83
(0.70, 0.99)]. In general, the pattern of associations between EED
and micronutrient deficiencies observed in univariate analyses
were also observed in the Bayesian network.
When evaluated within the Bayesian network (Figure 3),
all of the dietary associations with AGP were no longer
significant. Vitamin A nutrient density remained negatively
associated with each of the fecal biomarkers. Calcium and
vitamin B6 nutrient densities were each negatively associated
with MPO and AAT, and protein density was inversely associated
with MPO. Zinc nutrient density remained the only significant
(inverse) association with LMZ. Of note, vitamin B12 density
emerged in the Bayesian network as positively associated with
MPO.
Including associations with markers of gut function and AGP
(Figure 3), the association between vitamin A nutrient density
and plasma retinol was no longer significant [1.08 (0.80, 1.45)].
However, greater iron density remained associated with a lower
risk of low ferritin [0.73 (0.57, 0.92)], and with a lower risk
of high TfR [0.79 (0.63, 0.99)] and low retinol [0.74 (0.55,
0.99)]. However, the association with anemia was no longer
significant [0.86 (0.66, 1.12)]. The calcium nutrient density of
complementary foods was positively associated with elevated
TfR, in univariate analyses and in the Bayesian network [1.28
(1.01, 1.61)]. Similarly, vitamin A nutrient density was positively
associated with anemia in both sets of analyses [Bayesian
network OR: 1.52 (1.13, 2.02)].
Of the 3 additional characterizations of systemic inflammation,
only maternally reported fever in the 7 d prior to blood draw
was associated with a reduced risk of low ferritin (Supplemental

Figure 4). Inclusion of these variables did not affect other
coefficients in the model (Figure 3) except for a slight reduction
in the magnitude of AGP.

Discussion
The children participating in the MAL-ED study were
continuously exposed to multiple enteropathogens (23, 40,
41). The elevated biomarkers of gut function suggest that
their gastrointestinal systems experienced varying degrees of
inflammation, cellular immune activation, heightened permeability and damage as evidenced by protein loss (39, 42).
Although variable across sites, many children had anemia
and micronutrient deficiencies. Our results demonstrate that
biomarkers of gut function characterizing EED differentiate the
risk of micronutrient deficiency independent of dietary intake and
systemic inflammation.
The intake of micronutrients, shown here as nutrient densities
in complementary foods between 9 and 15 mo of age, differed
by site, were inadequate for iron in all sites, and except
for BRF, were largely inadequate for vitamin A and zinc
(when compared with the estimated average requirements for
children). With the exception of vitamin B12, greater nutrient
densities from complementary foods were associated with lower
intestinal inflammation and permeability, vitamin A density
was inversely associated with MPO, NEO, and AAT, and zinc
density was inversely associated with LMZ. Greater nutrient
densities of iron differentiated the risk of anemia, low ferritin,
and low retinol, and greater vitamin A density differentiated
the risk of low retinol. However, associations between nutrient
density and micronutrient deficiency largely disappeared when
biomarkers of EED were considered, suggesting that EED
mediated the associations between intake and micronutrient
status. Importantly, however, iron density from complementary
foods was not associated with any of the gut function markers,
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TABLE 4 Mean effect of a 1-SD change in nutrient densities from complementary foods on the concentration of biomarkers of environmental enteric
dysfunction and systemic inflammation (each of which was also scaled to mean 0, SD 1)1
Usual nutrient density, SD
[sqrt(intake/1000 kcal)]
Iron, mg
Zinc, mg
Calcium, mg
Vitamin A, μg
Vitamin B6, μg
Folate, μg
Vitamin B12, μg
Vitamin C, mg
Protein, g

MPO

NEO

AAT

LMZ

AGP

− 0.01 (−0.09, 0.07)
− 0.09 (−0.19, 0.01)
− 0.15 (−0.21, −0.08)∗
− 0.12 (−0.2, −0.04)∗
− 0.03 (−0.11, 0.05)
− 0.02 (−0.08, 0.04)
− 0.05 (−0.12, 0.03)
0 (−0.07, 0.08)
− 0.12 (−0.19, −0.06)∗

− 0.04 (−0.11, 0.03)
− 0.05 (−0.13, 0.04)
− 0.08 (−0.13, −0.03)∗
− 0.14 (−0.2, −0.07)∗
0.01 (−0.06, 0.08)
− 0.02 (−0.07, 0.04)
− 0.07 (−0.13, −0.01)∗
0.05 (−0.01, 0.11)
− 0.01 (−0.07, 0.04)

0.04 (−0.04, 0.12)
− 0.15 (−0.24, −0.05)∗
− 0.19 (−0.25, −0.13)∗
− 0.21 (−0.29, −0.14)∗
− 0.04 (−0.11, 0.04)
− 0.02 (−0.08, 0.04)
− 0.19 (−0.26, −0.13)∗
0.01 (−0.06, 0.08)
− 0.14 (−0.2, −0.07)∗

− 0.05 (−0.13, 0.03)
− 0.14 (−0.23, −0.04)∗
− 0.04 (−0.11, 0.02)
− 0.05 (−0.13, 0.02)
− 0.02 (−0.1, 0.06)
− 0.01 (−0.07, 0.06)
− 0.05 (−0.12, 0.02)
− 0.03 (−0.11, 0.04)
− 0.02 (−0.09, 0.04)

− 0.03 (−0.12, 0.05)
− 0.13 (−0.23, −0.04)∗
− 0.05 (−0.11, 0.02)
− 0.1 (−0.18, −0.02)∗
− 0.02 (−0.1, 0.06)
− 0.08 (−0.15, −0.02)∗
− 0.08 (−0.15, −0.01)∗
− 0.06 (−0.13, 0.02)
− 0.08 (−0.15, −0.01)∗

1 Nutrient densities were transformed using a square-root function, MPO, NEO, and AAT were transformed using a natural logarithm function and then
each, along with AGP, was scaled to mean 0, SD 1. ∗ indicates associations that do not include 0 in the 95% CI. AAT, α-1-antitrypsin; AGP, α-1-acid
glycoprotein; LMZ, lactulose:mannitol ratio z-score; MPO, myeloperoxidase; NEO, neopterin.

and in the Bayesian network, greater iron density remained
associated with a lower risk of low ferritin, high TfR, and low
retinol, all of which affect the risk of anemia in these children.
Unexpectedly, higher vitamin A nutrient density was positively
associated with the risk of anemia.

Nutrient densities from
complementary foods
[mean 9–15 mo]
zinc

The results related to iron status and anemia are noteworthy.
AAT is a large protein, mostly of hepatic origin, which may
be present in the gut in minor quantities from ingested breast
milk or local synthesis by Paneth cells (43, 44). However, it
is a positive acute-phase reactant in systemic circulation and

Biomarkers of gut inflammation (MPO,
NEO), gut permeability (AAT, LMZ), and
systemic inflammation (AGP)
[mean 9–15: MPO, NEO, AAT
mean 9 & 15 mo: LMZ
15 mo: AGP]

Biomarkers of micronutrient
status [15 mo]

low
zinc

LMZ

iron

high
TfR

calcium

AAT
low
ferritin

protein
NEO

vitamin
B12

AGP

low
retinol

MPO

vitamin
B6

anemia

vitamin
A

Significant

mean e ects
log odds

Positive
Negative

1
0.1

FIGURE 3 Results of the multivariate Bayesian network. Arcs (arrows) are shown for parameters that did not include zero in the 95th percentile credibility
interval. Positive associations are shown in red and negative in blue. The thickness of the arc is proportional to the magnitude of the association, with solid
lines indicating linear associations and dashed lines indicating log odds. AAT, α-1-antitrypsin; AGP, α-1 acid glycoprotein; LMZ, urinary lactulose:mannitol
ratio z-score; MPO, myeloperoxidase; NEO, neopterin; TfR, transferrin receptor.
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higher mean fecal AAT concentrations indicate loss of AAT
from systemic circulation through diffusion, greater permeability,
or mucosal damage (45, 46). This raises the question as to
whether other plasma proteins may be lost as well. Here, we
show that higher fecal AAT is associated with a greater risk
of low plasma ferritin, and is also positively associated with
LMZ, which is associated with a greater risk of anemia and low
retinol. A higher average MPO concentration was also associated
with a greater risk of anemia, and this is of interest because
MPO is an iron-containing protein released from neutrophils in
response to mucosal injury (47), and directly indicates loss of
iron from the body. Elevated TfR is an indicator of iron-deficient
erythropoiesis; here, we show that TfR is elevated with systemic
inflammation, in agreement with other reports (48, 49). That
higher average fecal MPO concentration was protective against
high TfR may result from cytokine stimulation which activates
NEO release and also increases hepcidin production, potentially
reducing TfR (47).
Not all of the associations indicated that gut dysfunction
was associated with increased risk of micronutrient deficiency.
Greater gut permeability (indicated by greater LMZ and greater
%Lac-Z) was associated with a lower risk of zinc deficiency,
which we postulate reflects greater passive absorption of zinc
across the mucosa. Unexpectedly, a higher NEO concentration
was associated with a lower risk of low retinol, and our
finding is inconsistent with the report by Wieringa et al. (50)
of significantly higher circulating NEO concentrations among
vitamin A–deficient infants. Further studies of the mechanisms
that regulate the production and turnover of both NEO and retinol
are needed to elucidate these (or our) results.
This study provides novel findings linking the nutrient density
of complementary foods with markers of gut function and
inflammation and systemic inflammation. Negative associations
between these biomarkers and nutrient densities involving
vitamins A and B6, calcium, zinc, iron, and protein were
detected during univariate analyses, with a few of these remaining
significant in the overall model, after adjustment for multiple
relations across dietary and gut function variables, systemic
inflammation, and micronutrient status. That protein, zinc, and
vitamin A intakes are key nutrients for the maintenance of gut
health has been established through preclinical studies (15). Our
findings from 7 sites across 3 continents suggest that greater
nutrient density from complementary foods may reduce the
gut permeability and inflammation of young children living in
poverty, who frequently experience bouts of illness and are
continuously exposed to enteropathogens.
As noted earlier, other studies have identified associations
between selected markers of EED and micronutrient status (11–
14); however, none have taken our comprehensive approach
of evaluating multiple aspects of diet, gut function, systemic
inflammation, and indicators of micronutrient deficiency. We
are able to do this because of the in-depth follow-up of these
children with multiple assessments of diet, gut function, and
micronutrient status. There are limitations, however; first, our
model required observations across each of the many variables
and this necessitated dropping from analyses some children
who were enrolled into the study who did not provide a 15mo blood sample, or the sample did not allow for all assays.
Imputation of data would have been challenging due to site bias
in missing values and would have resulted in dubious modeled
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results. It was unfortunate that we had to remove the SAV
data entirely due to previously identified quality control issues
related to the plasma zinc samples, and both BRF and TZH
were underrepresented in the analytical data set compared with
other sites. Second, despite having multiple indicators of gut
function, we assessed systemic inflammation using only AGP
and only at 1 time point; our additional analyses with reported
fever did not yield new insights, but other direct systemic markers
of immunological response would perhaps identify linkages
with gut function markers not observed here. Third, although
most of these children were breastfed, we have no data on
breast milk consumption or the nutrient composition of breast
milk; thus, our results do not refer to the nutrient density of
the total diet, but rather to that from nonbreast milk foods.
Finally, it should be noted that we did not evaluate absorption
directly, and cannot distinguish whether intestinal inflammation
and permeability disrupt nutrient absorption, increase nutrient requirements, and/or result in dysregulation of nutrient metabolism
such as occurs with systemic inflammation. Studies of children
in which enteropathogen exposure and markers of gut function
are characterized, and nutrient absorption is assessed, e.g., using
stable isotopes, are needed to provide further clarity (9), as are
studies which also assess regulators of micronutrient absorption
and metabolism.
In summary, this study provides novel findings on the relation
among gut permeability and inflammatory markers of EED and
the risk of micronutrient deficiencies in young children across
multiple low-resource settings. Greater nutrient densities from
complementary foods may reduce intestinal inflammation and
permeability, and reduce the risk of micronutrient deficiencies.
Apart from dietary intake and systemic inflammation, gut
permeability and inflammation affect the risk of micronutrient
deficiencies and anemia. These results underscore the need to
reduce ubiquitous enteropathogen exposure and EED, along
with improving the nutrient density of complementary foods,
as a coordinated strategy to reduce micronutrient deficiencies in
young children.
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